An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection?

Abstract

Management of later stage melanoma has undergone significant changes. Sentinel node biopsy has long been an accepted method of staging, but two recent randomized-controlled trials have provided an evidence base for decision making about completion lymphadenectomy. They showed no survival advantage in further surgery for patients with positive sentinel node biopsies. There is now no evidence to support completion lymphadenectomy in the majority of patients, and this is reflected in international practice guidelines.

Keywords

• DeCOG-SLT
• lymph node
• lymphadenectomy
• melanoma
• MSLT-2
• sentinel node